Skip to main content
OpenTrials

Clinical trial condition

Schizophrenia

Explore clinical trials studying Schizophrenia. Study availability and eligibility vary by location and protocol.

2,712 public trials 267 recruiting studies
Refine in advanced search Browse all conditions

Schizophrenia trial results

Completed

Safety and Tolerability of Open-Label Flexible-dose Brexpiprazole as Maintenance Treatment in Adolescents With Schizophrenia

NCT03238326

Conditions
Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations
  • Clinical Research Site #101 Dothan, Alabama, United States
  • Clinical Research Site #128 Anaheim, California, United States
  • Clinical Research Site #105 Culver City, California, United States
  • Clinical Research Site #103 Long Beach, California, United States
View all 57 locations
View Trial Details
Completed

Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective Disorder

NCT06319170

Conditions
Mental Disorders, Psychotic Disorders, Schizophrenia, +2 more
Locations
  • Teva Investigational Site 15730 Los Alamitos, California, United States
  • Teva Investigational Site 15727 Hollywood, Florida, United States
  • Teva Investigational Site 15729 Atlanta, Georgia, United States
  • Teva Investigational Site 15728 Decatur, Georgia, United States
View Trial Details
Completed

Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia

NCT05859698

Conditions
Bipolar Disorder, Bipolar and Related Disorders, Central Nervous System Diseases, +17 more
Locations
  • Neurocrine Clinical Site Bryant, Arkansas, United States
  • Neurocrine Clinical Site Anaheim, California, United States
  • Neurocrine Clinical Site Orange, California, United States
  • Neurocrine Clinical Site Torrance, California, United States
View all 18 locations
View Trial Details
Completed

An Open-Label Trial to Assess the Comparative Bioavailability of TV-44749 to Oral Olanzapine in Participants With Schizophrenia

NCT06315283

Conditions
Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations
  • Teva Investigational Site 15739 Los Alamitos, California, United States
  • Teva Investigational Site 15740 Torrance, California, United States
  • Teva Investigational Site 15738 Hollywood, Florida, United States
  • Teva Investigational Site 15741 Atlanta, Georgia, United States
View Trial Details

Related conditions